May 28, 2024

Vedolizumab, a monoclonal antibody used primarily in the treatment of inflammatory bowel diseases like Crohn’s disease and ulcerative colitis, has necessitated the development of precise assays for its detection and quantification in clinical settings. The Vedolizumab ELISA (Enzyme-Linked Immunosorbent Assay) is a critical tool for monitoring drug levels in patients, ensuring therapeutic efficacy and minimizing […]

Read More